Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia.

about

Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia.

Item

http://www.wikidata.org/entity/Q40941767

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Use of arsenic trioxide in a h ...... acute promyelocytic leukemia.

@en

type

Item

label

Use of arsenic trioxide in a h ...... acute promyelocytic leukemia.

@en

prefLabel

Use of arsenic trioxide in a h ...... acute promyelocytic leukemia.

@en

P1476

Use of arsenic trioxide in a h ...... acute promyelocytic leukemia.

@en

P2093

Julie Moeller

http://www.w3.org/2001/XMLSchema#string

Kejal Patel

http://www.w3.org/2001/XMLSchema#string

Kerry Russell

http://www.w3.org/2001/XMLSchema#string

Nikolai Podoltsev

http://www.w3.org/2001/XMLSchema#string

Rachel Eyler

http://www.w3.org/2001/XMLSchema#string

Sarah Perreault

http://www.w3.org/2001/XMLSchema#string

Trinh Pham

http://www.w3.org/2001/XMLSchema#string

P2860

The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia.

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.

Acute promyelocytic leukemia: evolving therapeutic strategies.

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group.

Cardiac monitoring of patients receiving arsenic trioxide therapy.

Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide.

Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical and basic studies.

Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma.

P304

646-651

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1078155215586235

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25972392

http://www.w3.org/2001/XMLSchema#string